GOYA, NCT01287741 / 2010-024194-39: A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma |
|
|
| Terminated | 3 | 1418 | Canada, Japan, US, Europe, RoW | Rituximab, MabThera, Rituxan, Obinutuzumab, GA101, RO5072759, Cyclophosphamide, Doxorubicin, Vincristine, Prednisone | Hoffmann-La Roche, Fondazione Italiana Linfomi ONLUS | Diffuse Large B-Cell Lymphoma | 04/16 | 01/18 | | |
| Terminated | 3 | 671 | Europe | GA101, obinutuzumab, Gazivaro, Rituximab, Mabthera, Doxorubicin, Cyclophosphamide, Prednisone, Bleomycin, Vindesin, Vincristine | The Lymphoma Academic Research Organisation, Hoffmann-La Roche | Diffuse Large B Cell Lymphoma CD20 Positive | 08/16 | 12/17 | | |